- $20.40bn
- $28.65bn
- $129.66bn
Annual cashflow statement for Humana, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2,934 | 2,802 | 2,484 | 1,214 | 1,203 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -1,014 | 231 | 499 | 738 | 566 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -386 | 809 | 248 | 238 | -1,747 |
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Gains / Losses on Investment Securities | |||||
| Change in Reinsurance Receivable | |||||
| Cash from Operating Activities | 2,262 | 4,587 | 3,981 | 2,966 | 921 |
| Capital Expenditures | -1,316 | -1,120 | -1,004 | -575 | -546 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -5,240 | 114 | -2,488 | -2,377 | 2,819 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -6,556 | -1,006 | -3,492 | -2,952 | 2,273 |
| Financing Cash Flow Items | -337 | 1,987 | 821 | -1,399 | -1,065 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3,015 | -1,914 | -856 | -2,487 | -1,215 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1,279 | 1,667 | -367 | -2,473 | 1,979 |